Biomarker-based phase I dose-escalation, pharmacokinetic, and pharmacodynamic study of oral apricoxib in combination with erlotinib in advanced nonsmall cell lung cancer

Cancer ◽  
2010 ◽  
Vol 117 (4) ◽  
pp. 809-818 ◽  
Author(s):  
Karen Reckamp ◽  
Barbara Gitlitz ◽  
Lin-Chi Chen ◽  
Ravi Patel ◽  
Ginger Milne ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Cell Lung Cancer ◽  
Dose Escalation ◽  
Nonsmall Cell Lung Cancer ◽  
Pharmacodynamic Study

A Phase I Dose Escalation Study of Weekly Docetaxel and Carboplatin in Elderly Patients With Nonsmall Cell Lung Cancer

2007 ◽  
Vol 30 (1) ◽  
pp. 51-56 ◽  
Author(s):  
Kyoichi Kaira ◽  
Satoshi Tsuchiya ◽  
Noriaki Sunaga ◽  
Noriko Yanagitani ◽  
Satoru Watanabe ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Phase I ◽  
Cell Lung Cancer ◽  
Dose Escalation ◽  
Nonsmall Cell Lung Cancer ◽  
Dose Escalation Study ◽  
Weekly Docetaxel

scholarly journals A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer

Cancer ◽  
2006 ◽  
Vol 107 (5) ◽  
pp. 1034-1041 ◽  
Author(s):  
Daniel T. Milton ◽  
Christopher G. Azzoli ◽  
Robert T. Heelan ◽  
Ennapadam Venkatraman ◽  
Jorge E. Gomez ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Cell Lung Cancer ◽  
Nonsmall Cell Lung Cancer ◽  
High Dose ◽  
Previously Treated Patients ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document